share_log

STERIS Expects FY25 As Reported Revenue From Continuing Operations To Increase 6.5%-7.5%; Adjusted EPS From Continuing Operations Of $9.05 - $9.25 (Est $9.33)

Benzinga ·  May 8 17:13

Capital expenditures are anticipated to be approximately $360 million and free cash flow is expected to be approximately $700 million.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment